GL1X · GenesisL1 explorer

Research workbench

Human hepatitis B viral capsid (hbcag)

Analyse Human hepatitis B viral capsid (hbcag) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1QGT
Type
protein
Length
570 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein (HBV capsid protein)
UniProt
Q67855
Pockets
6 · best druggability 0.72

Structure

x-ray diffraction · 2 distinct chains · 70% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
C, AProtein (HBV capsid protein)protein14272% helix, 0% strandQ67855
D, BProtein (HBV capsid protein)protein14369% helix, 0% strandQ67855

Pockets

6 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12870.720.8536empty
22400.720.8729empty
32900.690.8340empty
4750.340.7514empty
51000.340.7314empty

Interfaces

3 interfaces between chains.

  • C–D · 2047 Ų buried · 24 hydrogen bonds · protein-protein
  • B–A · 2039 Ų buried · 20 hydrogen bonds · protein-protein
  • C–B · 574 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 1QGT · Human hepatitis B viral capsid (hbcag) · the same entry in another collection · chain C against C, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.